The purpose of this study is to identify and quantify a brain energy deficit in Huntington patients, using 31P-RMN spectroscopy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
30
Brain energy deficit is quantified using 31P-MR spectroscopy
Brain energy deficit is quantified using 31P-RMN spectroscopy
Hopital de la Pitié-Salpetrière
Paris, France
Brain energy deficit in Huntington patients
31P-MRS allows quantification of high-energy phosphate metabolites such as ATP and phosphocreatine. Objective: to look at brain energy metabolism during rest and activation.
Time frame: one year
Correlating a brain energy deficit with (i) biochemical parameters and (ii) clinical parameters in Huntington patients
Biochemical parameters include metabolites that we previously showed to be biomarkers in HD: branched chain amino acids and IGF1. Clinical parameters include UHDRS and TFC.
Time frame: one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.